tiprankstipranks
Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
US Market

Aerovate Therapeutics (AVTE) Financial Statements

113 Followers

Aerovate Therapeutics Financial Overview

Aerovate Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.034; its P/E ratio is -0.56; Aerovate Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.62M$ -22.07M$ -19.59M$ -19.05M$ -17.38M
EBITDA$ -24.59M$ -22.04M$ -20.37M$ -19.66M$ -18.02M
Net Income Common Stockholders$ -23.19M$ -20.41M$ -19.59M$ -19.02M$ -16.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 99.33M$ 122.44M$ 135.20M$ 150.10M$ 118.93M
Total Assets$ 106.82M$ 127.42M$ 140.88M$ 155.75M$ 124.13M
Total Debt$ 774.00K$ 675.00K$ 809.00K$ 855.00K$ 964.00K
Net Debt$ -98.56M$ -121.76M$ -134.39M$ -149.24M$ -117.97M
Total Liabilities$ 15.92M$ 17.96M$ 15.15M$ 13.83M$ 11.30M
Stockholders Equity$ 90.90M$ 109.46M$ 125.72M$ 141.93M$ 113.09M
Cash Flow-
Free Cash Flow$ -23.67M$ -14.86M$ -15.64M$ -14.97M$ -11.44M
Operating Cash Flow$ -23.67M$ -14.80M$ -15.61M$ -14.94M$ -11.42M
Investing Cash Flow$ 8.83M$ 5.65M$ -13.13M$ 3.98M$ 15.38M
Financing Cash Flow$ 471.00K$ 463.00K$ 20.00K$ 45.29M$ 223.00K
Currency in USD

Aerovate Therapeutics Earnings and Revenue History

Aerovate Therapeutics Debt to Assets

Aerovate Therapeutics Cash Flow

Aerovate Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis